 |
0 Diseases |  |
4 Trials |
|
4 Trials |  |
59 News |  |
| «12 |
- | Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus, Brixadi once-monthly depot (buprenorphine once-monthly depot) / Camurus, Braeburn
New P2 trial: Phase II Pharmacokinetics Study of CAM2038 (clinicaltrials.gov) - Mar 16, 2016
P2, N=50, Recruiting, Sponsor: Braeburn Pharmaceuticals
- Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus
Trial primary completion date: A Multiple Dose Opioid Challenge Study (clinicaltrials.gov) - Mar 10, 2016
P2, N=48, Enrolling by invitation, Sponsor: Braeburn Pharmaceuticals
Trial primary completion date: Feb 2016 --> May 2016
- || Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus, Brixadi once-monthly depot (buprenorphine once-monthly depot) / Camurus, Braeburn
Enrollment status: Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder (clinicaltrials.gov) - Mar 3, 2016
P=N/A, N=160, Recruiting, Sponsor: Braeburn Pharmaceuticals
Trial primary completion date: Feb 2016 --> May 2016 Enrolling by invitation --> Recruiting
- ||||| Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus, Brixadi once-monthly depot (buprenorphine once-monthly depot) / Camurus, Braeburn
Enrollment status, Enrollment change: Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence (clinicaltrials.gov) - Feb 7, 2016
P3, N=252, Recruiting, Sponsor: Braeburn Pharmaceuticals
Enrolling by invitation --> Recruiting Enrolling by invitation --> Recruiting | N=180 --> 252
- ||| Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus, Brixadi once-monthly depot (buprenorphine once-monthly depot) / Camurus, Braeburn
New trial: Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=160, Enrolling by invitation, Sponsor: Braeburn Pharmaceuticals
- |||||||||| Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus, Brixadi once-monthly depot (buprenorphine once-monthly depot) / Camurus, Braeburn
New P3 trial: Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence (clinicaltrials.gov) - Jan 11, 2016
P3, N=180, Enrolling by invitation, Sponsor: Braeburn Pharmaceuticals
- | Brixadi once-weekly depot (buprenorphine once-weekly depot) / Braeburn, Camurus
New P2 trial: A Multiple Dose Opioid Challenge Study (clinicaltrials.gov) - Nov 24, 2015
P2, N=48, Enrolling by invitation, Sponsor: Braeburn Pharmaceuticals